Enoblituzumab
Catalogue number:
HY-P9966-10mg
Supplier:
Size:
10 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
CD276/B7-H3
Alternative Names:
MGA271
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators[1].




